Jasenka Piljac Žegarac, PhD

Jasenka is a scientist and professional freelance medical writer with expertise in a wide range of therapeutic and scientific areas. Her research articles have gathered more than 1200 citations. At The Scientist Writer LLC, she helps clients from the food, pharma, and biotech industries develop top-quality communications solutions. Find Jasenka on LinkedIn.

Most Recent Articles by Jasenka Piljac Žegarac, PhD

Addressing Palliative Care in Hepatocellular Carcinoma

Addressing Palliative Care in Hepatocellular Carcinoma

By

Research shows that palliative care can help with symptom management, care coordination, therapeutic decision making, and the psychosocial aspects of living with hepatocellular carcinoma.

Transfusion-Transmitted Hepatitis B Virus: Minimizing the Risk

Transfusion-Transmitted Hepatitis B Virus: Minimizing the Risk

By

The risk for HBV transfusion-transmitted infection has been significantly reduced in the last few decades by the careful selection of donors and testing of blood donations, using sensitive serological and molecular screening techniques.

Managing HBV Infection Following Liver Transplant: Expert Q&A

Managing HBV Infection Following Liver Transplant: Expert Q&A

By

In the past 2 decades, prophylactic antiviral therapies have drastically reduced the rates of HBV recurrence, allograft loss, and mortality in patients undergoing liver transplantation.

Universal Influenza Vaccine: A Game Changer in Prevention

Universal Influenza Vaccine: A Game Changer in Prevention

By

A dedicated research effort led by NIH's National Institute of Allergy and Infectious Diseases is aimed at developing a universal influenza vaccine that would confer better and longer-lasting protection against influenza virus strains.

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

Climate Change: Effects on the Incidence and Distribution of Infectious Diseases

By

Without proactive measures and response, the changing climate is projected to continue to adversely affect the global incidence and distribution of infectious diseases and cause 250,000 additional deaths per year between 2030 and 2050.

More Articles by Jasenka Piljac Žegarac, PhD

Sign Up for Free e-newsletters